AXT (AXTI) has had the highest return since January 1, 2026 by a mid-cap US stock, returning 619.7%.
| ASSET | % RETURN |
|---|---|
AXT (AXTI) | 619.65% |
MaxLinear (MXL) | 417.89% |
Aehr Test Systems (AEHR) | 373.36% |
Lightwave Logic (LWLG) | 320% |
Immunitybio (IBRX) | 294.55% |
Ichor (ICHR) | 281.81% |
Babcock & Wilcox Enterprises (BW) | 236.15% |
Ultra Clean (UCTT) | 228.77% |
P3 Health Partners (PIII) | 218.93% |
Veradermics (MANE) | 193.29% |
Navitas Semiconductor (NVTS) | 184.27% |
Silicon Motion Technology (SIMO) | 176.59% |
Erasca (ERAS) | 175.74% |
Enliven Therapeutics (ELVN) | 166.71% |
Vishay Intertechnology (VSH) | 152.49% |
POET Technologies (POET) | 139.79% |
Iridium Communications (IRDM) | 139% |
Penguin Solutions (PENG) | 135.51% |
Alumis (ALMS) | 134.08% |
Tango Therapeutics (TNGX) | 132.32% |
Day One Biopharmaceuticals (DAWN) | 131.75% |
Himax Technologies (HIMX) | 130.47% |
Spyre Therapeutics (SYRE) | 128.69% |
Nanobiotix (NBTX) | 126.77% |
Kulicke and Soffa Industries (KLIC) | 118.67% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.